Bio-Key International, Inc., Named Defendant in Suit by Investors, Action Seeks Redemption of Series B and C Preferred Stock

Share Article

The law firm of Smith & Associates announced today that it has filed a lawsuit against Bio-Key International, Inc. The claim was filed on behalf of investors who are holders of Bio-Key's Series B and C Preferred Stock. According to the complaint, Bio-Key has failed to fulfill its contractual obligations to redeem the Series B and C Preferred held by the investors.

The law firm of Smith & Associates announced today that it has filed a lawsuit against Bio-Key International, Inc. in the United States District Court for the Southern District of New York (Index No.: 09 Civ 00904). The claim was filed on behalf of investors who are holders of Bio-Key's Series B and C Preferred Stock.

According to the complaint, Bio-Key has failed to fulfill its contractual obligations to redeem the Series B and C Preferred held by the investors. This press release is being put out because Bio-Key has failed to disclose the lawsuit to its investors.

Plaintiffs are represented by Smith & Associates. Smith & Associates maximizes returns for investors and investment funds through litigation against companies not meeting their obligations.

For further information about the lawsuit please contact E. David Smith of Smith and Associates, at (212) 661-7010.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

E. David Smith
Visit website